The Diagnosis, Assessment and Treatment of Diffuse Parenchymal Lung Disease in Adults
Open Access
- 1 April 1999
- Vol. 54 (Supplement), S1-S28
- https://doi.org/10.1136/thx.54.suppl_1.s1
Abstract
These guidelines have been replaced by 2008 Guideline and 2013 NICE IPF Guideline CG163 Superseded By 2008 Guideline and 2013 NICE IPF Guideline CG163: BTS guidelines on the diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Thorax 1999 Apr; 54(Suppl 1): 1-28.Keywords
This publication has 100 references indexed in Scilit:
- Diagnosis of Pneumocystis carinii pneumonia in HIV antibody positive patients by simple outpatient assessments.Thorax, 1992
- Nilutamide pneumonitis: a report on eight patients.Thorax, 1992
- Open Lung Biopsy: A Safe, Reliable and Accurate Method for Diagnosis in Diffuse Lung DiseaseRespiration, 1992
- Rising mortality from cryptogenic fibrosing alveolitis.BMJ, 1990
- Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.Thorax, 1989
- Alveolar permeability in HIV antibody positive patients with Pneumocystis carinii pneumonia.Sexually Transmitted Infections, 1987
- Rate of improvement of pulmonary function in sarcoidosis during treatment with corticosteroids.Thorax, 1986
- High-Dose Intravenous Methylprednisolone Pulse Therapy as Initial Treatment in Cryptogenic Fibrosing AlveolitisRespiration, 1986
- Open lung biopsy in patients with diffuse pulmonary shadowing.Thorax, 1985
- Natural History and Treated Course of Usual and Desquamative Interstitial PneumoniaThe New England Journal of Medicine, 1978